引用本文:
【打印本页】   【下载PDF全文】   View/Add Comment  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3801次   下载 3038 本文二维码信息
码上扫一扫!
分享到: 微信 更多
川芎嗪治疗慢性肺源性心脏病72例疗效观察
秦利人
541001 广西,桂林市妇女儿童医院药剂科
摘要:
[摘要] 目的 分析川芎嗪治疗慢性肺心病的临床疗效。方法 全部病人采用基础治疗措施,治疗组加用川芎嗪治疗;对照组用洋地黄及硝酸甘油等常规方法治疗。结果 治疗组总有效率为88.9%,对照组总有效率为69.4%,治疗组高于对照组(P<0.05)。结论 川芎嗪可改善肺心病的血液微循环,降低肺动脉高压,改善心肺功能。
关键词:  川芎嗪  慢性肺源性心脏病
DOI:10.3969/j.issn.1674-3806.2010.10.31
分类号:R 541.4
基金项目:
The clinical effect of ligustrazine in the treatment of 72 chronic pulmonary heart disease
QIN Li-ren
Department of Pharmacy,Women and Children′s Hospital of Guilin,Guangxi 541001,China
Abstract:
[Abstract] Objective To analyze the clinical effect of ligustrazine in the treatment of chronic pulmonary heart disease.Methods All patients received foundation therapeutic measure,the treatment group (36 cases) was treated with ligustrazine;the control group (36 cases) was treated with digitalis and nitroglycerin etc.Results The treatment group′s total effective rate was 88.9%, the control group′s total effective rate was 69.4%, therapentic effect in the treatment group was better than that in the control group( P<0.05).Conclusion Ligustrazine can improve the blood microcirculation of patients with chronic pulmonary heart disease,lower pulmonary hypertension, and improve cardiorespiatory function.
Key words:  Ligustrazine  Chronic pulmonary heart disease